Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
about
Current status of biomarker research in neurologyPsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Neuropsychiatric characteristics of GBA-associated Parkinson disease.GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisNine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez DíazSpecifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.Cognitive decline in Parkinson disease.The psychosis spectrum in Parkinson disease.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Integrating Patient Concerns into Parkinson's Disease Management.Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.Glucocerebrosidase Mutations in Parkinson Disease.Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?A Meta-Analysis of -Related Clinical Symptoms in Parkinson's DiseaseReduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
P2860
Q26744505-4D212AA5-1403-4975-AF39-2EA31780BFD2Q30249553-A0AC5BF1-712D-4D1D-8C1B-946886EAF4B6Q30275630-D380CB18-0D3F-48F5-8CC0-FD6D78FB0890Q36234536-84A68BAF-DA3F-4F76-BBE3-8632299719C6Q36885946-B91C7161-BC81-4540-AE09-B131EE3FD5DFQ37414072-B6ADBDA7-8964-44F6-8EE7-753EC2F384B8Q37593728-9A73F66E-2DB1-4157-9B8C-7787519E6761Q37696004-9DF2FC6C-A365-47AD-B2E2-ADD107B553B0Q38751099-8CF40BF5-9634-4BD3-B54F-B2A98623ABF6Q38768169-0E3EF87C-075A-49BF-BEDB-571155F1DB95Q38894971-9C659E4E-AAE5-4C4A-AA4F-69105A92258BQ39094808-801A4EDB-1F19-4661-8A45-AC49C6A9C304Q39332667-62A5BF27-8072-4862-9E48-A3A4ECE4FB46Q39362339-43FDDC49-B104-4B68-BECC-2228F2B92A69Q39386374-FB47B018-195C-49F9-9DBA-C244A32254A8Q47555107-A6A73A4F-B3D6-409A-8B01-0D7D93D52BCAQ54982491-4522735A-999F-4FD9-9790-DD37030B51F7Q58549914-C3A3A7FA-AA89-461A-98AA-926CB728D90EQ58603525-BA5743A0-5BA3-42C1-8150-71BF54AE83CD
P2860
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@en
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@nl
type
label
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@en
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@nl
prefLabel
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@en
Impact of glucocerebrosidase m ...... ations in Parkinson's disease.
@nl
P2093
P1476
Impact of glucocerebrosidase m ...... cations in Parkinson's disease
@en
P2093
Harutoshi Fujimura
Hiroshi Hasegawa
Hiroshi Sugiyama
Kimiko Inoue
Kwiyoung Park
Masayuki Kohsaka
Satoshi Tomita
Tomoko Oeda
P304
P356
10.1016/J.NEUROBIOLAGING.2015.08.027
P577
2015-09-07T00:00:00Z